Arkolith/Insider Trading/ARCT/Form 4

Chivukula Pad

Chief Scientific Officer & COOArcturus Therapeutics Holdings Inc. (ARCT) · full profile →Form 4 · filed May 12, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$752K
Net Open-Market Flow
-$752K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2023Sell(S)8K$30.24$240K554K
May 10, 2023Sell(S)17K$30.00$512K562K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-23-000719) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Arcturus Therapeutics Holdings Inc.

Build

Ask your agent about ARCT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193805-23-000719"
Ask your agent
Use Arkolith to summarize insider buying and selling at Arcturus Therapeutics Holdings Inc.
over the last 90 days and cite the filings.